A multicenter, open-label, long-term safety and tolerability study of DFN02, an intranasal spray of sumatriptan 10 mg plus permeation enhancer DDM, for the acute treatment of episodic migraine - Munjal, S; Brand-Schieber, E; Allenby, K (J Headache Pain, 2017)
et al.